270 related articles for article (PubMed ID: 32912901)
1. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
Agarwal S; Bell CM; Rothbart SB; Moran RG
J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
[TBL] [Abstract][Full Text] [Related]
3. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 silencing during intestinal epithelial Caco-2 cell differentiation is mediated by the activation of the AMPK/TSC2 pathway.
Kaur H; Moreau R
Biochem Biophys Res Commun; 2021 Mar; 545():183-188. PubMed ID: 33561653
[TBL] [Abstract][Full Text] [Related]
5. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
[TBL] [Abstract][Full Text] [Related]
6. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction.
Hong-Brown LQ; Brown CR; Kazi AA; Huber DS; Pruznak AM; Lang CH
J Cell Biochem; 2010 Apr; 109(6):1172-84. PubMed ID: 20127721
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
8. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
9. Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin.
Kwon B; Querfurth HW
Biochimie; 2015 Nov; 118():141-50. PubMed ID: 26344902
[TBL] [Abstract][Full Text] [Related]
10. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
11. Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex.
Kim SH; Yu HS; Huh S; Kang UG; Kim YS
Psychopharmacology (Berl); 2022 Feb; 239(2):443-454. PubMed ID: 34716784
[TBL] [Abstract][Full Text] [Related]
12. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Kalender A; Selvaraj A; Kim SY; Gulati P; Brûlé S; Viollet B; Kemp BE; Bardeesy N; Dennis P; Schlager JJ; Marette A; Kozma SC; Thomas G
Cell Metab; 2010 May; 11(5):390-401. PubMed ID: 20444419
[TBL] [Abstract][Full Text] [Related]
13. RIPK1 Promotes Energy Sensing by the mTORC1 Pathway.
Najafov A; Luu HS; Mookhtiar AK; Mifflin L; Xia HG; Amin PP; Ordureau A; Wang H; Yuan J
Mol Cell; 2021 Jan; 81(2):370-385.e7. PubMed ID: 33271062
[TBL] [Abstract][Full Text] [Related]
14. The association of AMPK with ULK1 regulates autophagy.
Lee JW; Park S; Takahashi Y; Wang HG
PLoS One; 2010 Nov; 5(11):e15394. PubMed ID: 21072212
[TBL] [Abstract][Full Text] [Related]
15. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling.
Burgos SA; Kim JJ; Dai M; Cant JP
Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179
[TBL] [Abstract][Full Text] [Related]
16. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
17. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
[TBL] [Abstract][Full Text] [Related]
18. Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex.
Karalis V; Caval-Holme F; Bateup HS
Nat Commun; 2022 Aug; 13(1):4665. PubMed ID: 35945201
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
20. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]